Trial
NCT03145480
Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwell Health
Collaborators
Pharmacyclics LLC.
Condition
Richter Syndrome
Intervention
Obinutuzumab
Why stopped
Investigator decision to close study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-06-01